Jennifer Ho is a Cardiology physician. ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Research metrics aren't shown for this record. Either we found no confident publication match for this name, or more than one physician shares the matched author record. We'd rather show nothing than someone else's numbers. Why? →
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
732 Harrison Ave
Preston, 3rd Floor
Boston, MA 021182309
Telephone
617-638-7490Registry record last updated 16 Jun 2014.
Clinical trials
- DAS181 for STOP COVID-19
Sponsor: Ansun Biopharma, Inc.
- DAS181 for Patients With Severe Hospitalized Flu and SAD-RVs (COVID-19)
Sponsor: Ansun Biopharma, Inc.
- Cardiometabolic Disease and Pulmonary Hypertension
Sponsor: Massachusetts General Hospital
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Eli Lilly and CompanyProgram year20251 payment
- Abbott LaboratoriesProgram year20212 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
100%Angiotensin receptor-neprilysin inhibitor (ARNI)47.5%Entresto100%Part D<11 patientsBeta blocker27.1%Metoprolol Succinate100%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
7 NIH research awards on record, funded 2013–2026 per NIH RePORTER. The latest:
- Endothelial Cell Health Across the Spectrum of Cardiometabolic Disease
Boston University Medical Campus
FY2026$739,545R01HL168889 - Mentoring in Patient-Oriented and Translational HFpEF Research
Beth Israel Deaconess Medical Center
FY2026$131,365K24HL153669 - Endothelial Cell Health Across the Spectrum of Cardiometabolic Disease
Boston University Medical Campus
FY2025$759,238R01HL168889
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
Gregory Y.H. Lip
Medical University of Białystok
Mika Kivimäki
University of Helsinki
Salim Yusuf
Population Health Research Institute
Victoria Delgado
Institute of Molecular Bioimaging and Physiology
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”